Hinye Pharmaceutical Co.,Ltd.
As of 18 November 2026, for the company name Hinye Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 27 active records with this name as holder; 20 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
42 acceptance records as first applicant, grouped into 30 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Empagliflozin Tablets 5 records · Latest accepted 2026/11/17
Supplement · 3Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2602093 | Supplement | 2026/11/17 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2602092 | Supplement | 2026/11/17 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2302357 | Supplement | 2023/10/25 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2200114 | Generic | 2022/01/18 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2200113 | Generic | 2022/01/18 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
小儿清热消炎宁颗粒 · No verified English name 1 records · Latest accepted 2026/10/29
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2600057 | New drug | 2026/10/29 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Acarbose Tablets 1 records · Latest accepted 2026/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602591 | Generic | 2026/10/22 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
活络消痛胶囊 · No verified English name 2 records · Latest accepted 2026/03/19
Supplement · 2
Dotinurad Tablets 2 records · Latest accepted 2025/12/30
Generic · 2
Baricitinib Tablets 1 records · Latest accepted 2025/10/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503843 | Generic | 2025/10/31 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
独一味胶囊 · No verified English name 1 records · Latest accepted 2025/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZS2500007 | Generic | 2025/06/14 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Finerenone Tablets 1 records · Latest accepted 2024/12/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404406 | Generic | 2024/12/19 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Vonoprazan Fumarate Tablets 1 records · Latest accepted 2024/10/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403416 | Generic | 2024/10/12 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Glucosamine Sulfate Capsules 1 records · Latest accepted 2024/10/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403382 | Generic | 2024/10/11 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Dapagliflozin Tablets 1 records · Latest accepted 2024/07/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402364 | Generic | 2024/07/26 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
注射用HYH2006078P1 · No verified English name 1 records · Latest accepted 2024/01/31
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400124 | New drug | 2024/01/31 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2024/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400083 | Generic | 2024/01/06 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
HYR04胶囊 · No verified English name 1 records · Latest accepted 2023/07/20
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZL2300051 | New drug | 2023/07/20 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
HYZ2001胶囊 · No verified English name 1 records · Latest accepted 2023/04/24
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZL2300030 | New drug | 2023/04/24 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
HYR0201颗粒 · No verified English name 1 records · Latest accepted 2023/01/20
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZL2300003 | New drug | 2023/01/20 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Sildenafil Citrate Oral Disintegrating Tablets 1 records · Latest accepted 2022/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201165 | Generic | 2022/07/28 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Apixaban Tablets 1 records · Latest accepted 2022/07/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201093 | Generic | 2022/07/25 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Levetiracetam Tablets 2 records · Latest accepted 2022/06/21
Generic · 2
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2022/04/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200645 | Generic | 2022/04/26 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Rivaroxaban Tablets 2 records · Latest accepted 2022/04/13
Generic · 2
Escitalopram Oxalate Tablets 2 records · Latest accepted 2022/02/23
Generic · 2
Rosuvastatin Calcium Tablets 2 records · Latest accepted 2022/02/10
Generic · 2
铝碳酸镁颗粒 · No verified English name 1 records · Latest accepted 2021/09/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150837 | Supplement | 2021/09/02 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2021/04/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101117 | Generic | 2021/04/30 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
复方益肝灵胶囊 · No verified English name 1 records · Latest accepted 2021/04/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101073 | Supplement | 2021/04/27 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
清热消炎宁片 · No verified English name 1 records · Latest accepted 2021/04/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101070 | Supplement | 2021/04/27 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
炎可宁丸 · No verified English name 1 records · Latest accepted 2021/04/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2101072 | Supplement | 2021/04/27 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Memantine Hydrochloride Tablets 1 records · Latest accepted 2021/01/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100088 | Generic | 2021/01/21 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Pregabalin Capsules 3 records · Latest accepted 2021/01/11
Generic · 3
Changes in the last 90 days
4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 4 applications
- 2026/11/17Accepted
Empagliflozin Tablets
CYHB2602093
Fact date: 2026/11/17 · Date added to this site: 2026/11/18
View source ↗ - 2026/11/17Accepted
Empagliflozin Tablets
CYHB2602092
Fact date: 2026/11/17 · Date added to this site: 2026/11/18
View source ↗ - 2026/10/29Accepted
小儿清热消炎宁颗粒 · No verified English name
CXZS2600057
Fact date: 2026/10/29 · Date added to this site: 2026/10/30
View source ↗ - 2026/10/22Accepted
Acarbose Tablets
CYHS2602591
Fact date: 2026/10/22 · Date added to this site: 2026/10/23
View source ↗
Under review
10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Empagliflozin Tablets | CYHB2602093 | Supplement | 2026/11/17 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Empagliflozin Tablets | CYHB2602092 | Supplement | 2026/11/17 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| 小儿清热消炎宁颗粒 · No verified English name | CXZS2600057 | New drug | 2026/10/29 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Acarbose Tablets | CYHS2602591 | Generic | 2026/10/22 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Dotinurad Tablets | CYHS2504481 | Generic | 2025/12/30 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Baricitinib Tablets | CYHS2503843 | Generic | 2025/10/31 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Dotinurad Tablets | CYHS2503112 | Generic | 2025/08/25 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| 独一味胶囊 · No verified English name | CYZS2500007 | Generic | 2025/06/14 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Finerenone Tablets | CYHS2404406 | Generic | 2024/12/19 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Upadacitinib Sustained-release Tablets | CYHS2400083 | Generic | 2024/01/06 | Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
Catalogue holder records
27 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Vonoprazan Fumarate Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20263248 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glucosamine Sulfate Capsules | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20256245 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20255293 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20247161 | 2024/07/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apixaban Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234653 | 2023/12/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levetiracetam Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234599 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levetiracetam Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234600 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234329 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234328 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Escitalopram Oxalate Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234063 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate Capsules | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234070 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Escitalopram Oxalate Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234062 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20233507 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rosuvastatin Calcium Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20233495 | 2023/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rosuvastatin Calcium Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20233494 | 2023/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tenofovir alafenamide Fumarate Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20233278 | 2023/03/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 铝碳酸镁颗粒 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20113186 | 2022/09/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Memantine Hydrochloride Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20223406 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20223305 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20223306 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20223307 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tofacitinib Citrate Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20213360 | 2021/05/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lamivudine Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20203688 | 2020/12/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entecavir Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20203408 | 2020/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entecavir Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20203407 | 2020/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atorvastatin Calcium Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20203358 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | Hinye Pharmaceutical Co.,Ltd. | Hinye Pharmaceutical Co.,Ltd. | 国药准字H20234567 | 2023/11/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| L-焦谷氨酸艾托格列净 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20250001319 | I | 2025/12/23 | CDE ↗ |
| 多替诺雷 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20250000660 | A | 2026/10/12 | CDE ↗ |
| 腺苷 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20250000400 | I | 2025/04/28 | CDE ↗ |
| 乌帕替尼 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20240001316 | A | 2026/06/23 | CDE ↗ |
| 富马酸伏诺拉生 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20240000949 | A | 2025/12/17 | CDE ↗ |
| 非奈利酮 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20240000913 | A | 2026/03/26 | CDE ↗ |
| 达格列净 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20240000242 | A | 2025/09/04 | CDE ↗ |
| 巴瑞替尼 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20240000146 | A | 2026/07/16 | CDE ↗ |
| 乌帕替尼 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20230000796 | A | 2026/06/23 | CDE ↗ |
| 恩格列净 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20210001202 | A | 2026/07/02 | CDE ↗ |
| 利伐沙班 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20210001204 | A | 2024/06/15 | CDE ↗ |
| 阿哌沙班 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20210000698 | A | 2024/06/15 | CDE ↗ |
| 富马酸丙酚替诺福韦 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20210000047 | A | 2025/08/28 | CDE ↗ |
| 坎地沙坦酯 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20190007467 | A | 2024/01/27 | CDE ↗ |
| 甲苯磺酸妥舒沙星 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20190006533 | A | 2026/08/04 | CDE ↗ |
| 枸橼酸托法替布 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20190000509 | A | 2026/05/09 | CDE ↗ |
| 塞来昔布 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20180001654 | I | 2019/03/13 | CDE ↗ |
| 盐酸乐卡地平 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20170001301 | A | 2024/04/29 | CDE ↗ |
| 米力农 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20170001190 | A | 2023/07/15 | CDE ↗ |
| 盐酸法舒地尔 · No verified English name | Hinye Pharmaceutical Co.,Ltd. | Y20170000283 | A | 2023/12/05 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
4 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 唑尼沙胺胶囊 · No verified English name | CYHS2601662 | Generic | 2026/07/13 | Hunan Shang Zhong He Biopharmaceuticals Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| 唑尼沙胺片 · No verified English name | CYHS2504341 | Generic | 2025/12/22 | Hunan Shang Zhong He Biopharmaceuticals Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| 复方聚乙二醇电解质散(II) · No verified English name | CYHS2501876 | Generic | 2025/05/27 | Hunan Run Xing Pharma Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | CYHB2402166 | Supplement | 2024/12/19 | Hubei Fu Rui Long Pharma Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.